Recent Quotes (30 days)

You have no recent quotes
chg | %

Hamilton Thorne Ltd  

(Public, CVE:HTL)   Watch this stock  
Find more results for HTL
-0.010 (-1.39%)
Oct 18 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.71 - 0.72
52 week 0.26 - 1.05
Open 0.71
Vol / Avg. 28,500.00/66,852.00
Mkt cap 76.72M
P/E 94.41
Div/yield     -
EPS 0.01
Shares 108.04M
Beta 3.12
Inst. own     -
Nov 27, 2017
Q3 2017 Hamilton Thorne Ltd Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Aug 24, 2017
Q2 2017 Hamilton Thorne Ltd Earnings Call
Aug 23, 2017
Q2 2017 Hamilton Thorne Ltd Earnings Release
Aug 22, 2017
Q2 2017 Hamilton Thorne Ltd Earnings Call

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 0.55% 6.46%
Operating margin 7.98% 9.30%
EBITD margin - 12.00%
Return on average assets 0.56% 7.02%
Return on average equity 1.32% 26.96%
CDP Score - -


100 Cummings Ctr Ste 465e
BEVERLY, MA 01915-6143
United States - Map
+1-978-9212050 (Phone)
+1-978-9210250 (Fax)

Website links


Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products. Its Clinical lasers include LYKOS laser and ZILOS-tk laser for applications, such as laser-assisted hatching and embryo biopsy for pre-implantation genetic diagnosis (PGD). Its Research lasers include XYRCOS laser, XYClone laser and Stiletto laser for applications, such as transgenic animal production, stem cell applications and somatic cell nuclear transfer. Its Clinical Sperm Analysis Products include IVOS II Clinical, CEROS II Clinical and Dimensions II Strict Morphology for applications, such as fertility testing, reproductive toxicology, animal breeding and biological research.

Officers and directors

Meg D. Spencer Chairman of the Board
David Wolf President, Chief Executive Officer, Director, IR Contact Officer
Michael W. Bruns CPA Chief Financial Officer, Vice President - Finance
Diarmaid H. Douglas-Hamilton Corporate Secretary, Chief Technology Officer and Senior Vice-President - Research & Development of the Corporation, Director
Thomas Kenny Vice President - Engineering
David B. Sable M.D. Director
Dean Gendron Independent Director
Bruno C. Maruzzo Independent Director
Age: 61
Robert J. Potter Independent Director
Daniel K. Thorne Independent Director
Age: 53